Treatment with OMP led to a 49% decrease in cortisol levels and a 36% reduction in gastrin levels in the ulcer group, whereas OMP-NS further lowered cortisol levels by roughly 75% and gastrin levels by around 61% (Figure 9). Here, GAST is linked to ulcer disease.